Characterization of ligurian melanoma families and risk of occurrence of other neoplasia
Open Access
- 10 November 1999
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 83 (4), 441-448
- https://doi.org/10.1002/(sici)1097-0215(19991112)83:4<441::aid-ijc2>3.0.co;2-r
Abstract
Germline mutations impairing the p16INK4‐function have previously been demonstrated to be responsible for genetic predisposition in at least one half of melanoma‐prone kindreds of North European origin. Familial melanoma kindreds have also been found to present an increased risk of pancreatic cancer and other cancers, but results relative to more common neoplasias incidence, in particular, are heterogeneous. We report here a clinical‐epidemiological study, including the presence of additional neoplasias, in 14 apparently unrelated kindreds coming from a small geographic region of Northern Italy (Liguria), having therefore lived for generations in similar environmental conditions. We identified the common p16 missense mutation (Gly101Trp) reported in several previously studied kindreds, in 7 of 14 families, whereas the remaining 7 families had no detectable mutations in the coding region of p16 gene. Median age at diagnosis and other melanoma features were studied. When compared with the expected figures, based on regional incidence rates, a significant excess of pancreatic cancer, with 4 cases diagnosed, and of breast cancer, with 7 cases, was observed. The 7 families without apparent CDKN2A involvement were also negative for hot‐spot exon 2 mutation of CDK4. Environmental factors do not appear to play a role in the excess of non‐melanoma neoplasia in our families, as somewhat substantiated by the control group, composed of spouses and members of non‐affected branches; they do not reveal any increased cancer incidence compared with the general population. Furthermore, given the proven significance of interaction between the melanoma susceptibility gene and the propensity to sunburns and other environmental risk factors, our results, obtained from a small but homogeneous sample, may have important implications for further risk assessment studies. Int. J. Cancer 83:441–448, 1999.This publication has 22 references indexed in Scilit:
- Interaction of breast cancer and melanoma genotypesThe Lancet, 1997
- Familial Tumor Syndrome Associated With a Germline Nonfunctional p16INK4a AlleleJNCI Journal of the National Cancer Institute, 1996
- Germline mutations in the p16INK4a binding domain of CDK4 in familial melanomaNature Genetics, 1996
- A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor GeneNew England Journal of Medicine, 1995
- Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindredsHuman Molecular Genetics, 1995
- Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindredsNature Genetics, 1995
- Mutations associated with familial melanoma impair p16INK4 functionNature Genetics, 1995
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locusNature Genetics, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993